Temasek and CVC Capital Partners Acquire Majority Stake in Alvogen
Posted on 06/22/2015
Singapore’s Temasek Holdings and private equity giant CVC Capital Partners are purchasing a controlling interest in New Jersey-based Alvogen, a generic drugs pharmaceutical company. The transaction values Alvogen at US$ 2 billion. Increasingly, institutional investors are spending more capital on healthcare company, specifically pharmaceutical companies. In Portuguese, alvo means target or goal. Owners of Alvogen […]
